Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
824,56 B | 23,56% | 6/6 | 34,75% | 10,44% | 36,74% | UP |
|
Johnson & Johnson NYSE:JNJ |
544,59 B | 5,26% | 5/5 | 7,04% | -23,28% | 14,55% | UP |
|
Merck NYSE:MRK |
278,83 B | 7,67% | 6/6 | -21,36% | -5,07% | 19,59% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
120,05 B | 1,77% | 5/6 | -0,30% | -1,11% | 8,84% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
111,33 B | 13,44% | 6/6 | 6,43% | -1,08% | 27,49% | DOWN |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
76,61 B | 9,26% | 5/6 | 5,41% | 5,25% | 17,54% | UP |
|
Zoetis NYSE:ZTS |
49,42 B | 9,80% | 6/6 | 7,18% | 47,53% | 23,38% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
25,16 B | 15,13% | 5/6 | 2,41% | -47,74% | 14,95% | UP |
|
Viatris NasdaqGS:VTRS |
16,91 B | -3,69% | 4/6 | 2,85% | -47,07% | 17,08% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
12,14 B | 0,00% | 2/4 | 0,00% | 0,00% | 22,27% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Cytokinetics NasdaqGS:CYTK |
8,16 B | -1,08% | 1/6 | 4,92% | -44,33% | 41,13% | UP |
|
Balchem NasdaqGS:BCPC |
5,61 B | 8,75% | 6/6 | 8,46% | 0,27% | 15,60% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
5,66 B | 63,45% | 3/5 | 33,54% | 92,20% | 20,07% | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,93 B | 28,91% | 5/6 | 13,62% | -4,99% | 10,27% | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
4,95 B | 10,36% | 5/6 | 118,76% | 11,18% | 28,84% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,52 B | 7,83% | 5/6 | 3,60% | -67,32% | 8,65% | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,90 B | 2,48% | 3/6 | 8,61% | -28,19% | 29,25% | UP |
|
Nektar Therapeutics NasdaqCM:NKTR |
2,67 B | 65,15% | 4/6 | 74,02% | -573,53% | 60,94% | UP |
|
Soleno Therapeutics NasdaqCM:SLNO |
2,73 B | 0,00% | 3/4 | 0,00% | 0,00% | 0,47% | UP |
